rs1555539827
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016239.4(MYO15A):c.3026delC(p.Pro1009LeufsTer49) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,586 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016239.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 247954Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134994
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460586Hom.: 0 Cov.: 44 AF XY: 0.00000138 AC XY: 1AN XY: 726580
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Pro1009Leufs*49) in the MYO15A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with MYO15A-related conditions. ClinVar contains an entry for this variant (Variation ID: 506256). For these reasons, this variant has been classified as Pathogenic. -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
Rare genetic deafness Pathogenic:1
The p.Pro1009fs variant in MYO15A has not been previously reported in individual s with hearing loss, but has been identified in 1/111138 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Alt hough this variant has been seen in the general population, its frequency is low enough to be consistent with the carrier frequency for recessive nonsyndromic h earing loss. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 1009 and leads to a prematur e termination codon 49 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein, and truncating variants in this regio n of the protein in individuals with hearing loss have been previously reported by our laboratory and in ClinVar. In summary, this variant meets criteria to be classified as pathogenic for hearing loss in an autosomal recessive manner based on the predicted impact of the variant. ACMG/AMP Criteria applied: PVS1, PM2, P M1. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at